KEROS THERAPEUTICS INC (KROS) Institutional Ownership and Insiders Activity

KEROS THERAPEUTICS INC (KROS) is widely held by institutional investors, with 131 firms reporting positions valued at approximately $198.47M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Blackrock, Inc. is the largest disclosed holder, reporting approximately $29.90M in KROS holdings in its latest filing.

Recent insider activity includes 7 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.